The Marcus Corporation MCS · NYSE
$28.71 +1.32% (+$0.38)
Summary
43 / 100 · Bulios Score
What speaks for it
- It passes 9 of the 9 points of the Piotroski financial health test.
- The price moves less than the market (beta 0.51).
What to watch
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 3.8% a year over the last 3 years against 26% over 5 years.
- Out of every 100 USD of revenue, only 2.9 USD is left as net profit.
- It earns only 3.6 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 38.5 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 3.8% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales -12 USD
- Sales and administration 108 USD
- Taxes and other 1.2 USD
- Net profit 2.9 USD
Net profit, industry median (Entertainment) 3.7 USD
Out of every 100 USD of revenue, 2.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.17%
- Paid out of profit
- 45%
- Raised in a row
- 3 years
You receive $0.33 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $33.5 is 17% above today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Admission 31%
- Concessions 28%
- Occupancy 16%
- Product and Service, Other 14%
- Food and Beverage 12%
By region
The company reports no revenue by region.
Admission brings in 31% of revenue. Product and Service, Other grew fastest, by 8.5% a year.
Segments in detail